AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $99,000 | -64.0% | 1,642,296 | 0.0% | 0.00% | – |
| Q2 2022 | $275,000 | -79.9% | 1,642,296 | -43.6% | 0.00% | – |
| Q1 2022 | $1,368,000 | -22.0% | 2,912,681 | -5.3% | 0.00% | – |
| Q4 2021 | $1,753,000 | -66.1% | 3,075,557 | -1.2% | 0.00% | -100.0% |
| Q3 2021 | $5,167,000 | +3.8% | 3,112,761 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $4,978,000 | +104.9% | 2,981,108 | +107.4% | 0.00% | – |
| Q1 2021 | $2,429,000 | +23.5% | 1,437,480 | +16.2% | 0.00% | – |
| Q4 2020 | $1,967,000 | +129.0% | 1,237,521 | +37.8% | 0.00% | – |
| Q3 2020 | $859,000 | +66.2% | 897,879 | +10.6% | 0.00% | – |
| Q2 2020 | $517,000 | +75.3% | 812,062 | +14.2% | 0.00% | – |
| Q1 2020 | $295,000 | -64.2% | 711,284 | -49.7% | 0.00% | – |
| Q4 2019 | $824,000 | +132.8% | 1,415,366 | +100.0% | 0.00% | – |
| Q3 2019 | $354,000 | +58.0% | 707,683 | +22.0% | 0.00% | – |
| Q2 2019 | $224,000 | -58.0% | 580,080 | -38.9% | 0.00% | – |
| Q1 2019 | $533,000 | -21.6% | 949,286 | -45.0% | 0.00% | – |
| Q4 2018 | $680,000 | +61.9% | 1,727,422 | +108.9% | 0.00% | – |
| Q3 2018 | $420,000 | -72.4% | 826,976 | +19.5% | 0.00% | – |
| Q2 2018 | $1,522,000 | -8.1% | 692,173 | +42.0% | 0.00% | -100.0% |
| Q1 2018 | $1,657,000 | -16.4% | 487,410 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,983,000 | +1249.0% | 487,410 | +101.9% | 0.00% | – |
| Q3 2017 | $147,000 | +15.7% | 241,370 | -1.0% | 0.00% | – |
| Q2 2017 | $127,000 | -49.2% | 243,814 | -22.1% | 0.00% | – |
| Q1 2017 | $250,000 | -8.8% | 313,183 | +2.8% | 0.00% | – |
| Q4 2016 | $274,000 | +22.9% | 304,693 | +0.9% | 0.00% | – |
| Q3 2016 | $223,000 | -41.0% | 301,895 | +2.9% | 0.00% | – |
| Q2 2016 | $378,000 | -26.0% | 293,398 | +29.0% | 0.00% | – |
| Q1 2016 | $511,000 | -35.8% | 227,448 | 0.0% | 0.00% | – |
| Q4 2015 | $796,000 | +21.2% | 227,448 | 0.0% | 0.00% | – |
| Q3 2015 | $657,000 | +34.9% | 227,448 | +10.6% | 0.00% | – |
| Q2 2015 | $487,000 | -72.8% | 205,605 | -13.4% | 0.00% | -100.0% |
| Q1 2015 | $1,788,000 | +123.2% | 237,550 | +1.6% | 0.00% | – |
| Q4 2014 | $801,000 | -2.9% | 233,811 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $825,000 | -57.7% | 233,811 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,952,000 | +56.4% | 233,811 | +18.9% | 0.00% | 0.0% |
| Q1 2014 | $1,248,000 | +16.6% | 196,618 | +31.0% | 0.00% | 0.0% |
| Q4 2013 | $1,070,000 | +13.3% | 150,110 | +19.2% | 0.00% | 0.0% |
| Q3 2013 | $944,000 | +56.3% | 125,912 | +20.3% | 0.00% | 0.0% |
| Q2 2013 | $604,000 | – | 104,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|